PortfoliosLab logoPortfoliosLab logo
GERM vs. VFQY
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

GERM vs. VFQY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amplify Treatments, Testing and Advancements ETF (GERM) and Vanguard U.S. Quality Factor ETF (VFQY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


GERM

1D
0.00%
1M
0.00%
YTD
0.00%
6M
0.00%
1Y
0.00%
3Y*
5Y*
10Y*

VFQY

1D
-0.31%
1M
3.82%
YTD
7.68%
6M
7.73%
1Y
18.92%
3Y*
16.10%
5Y*
8.37%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

GERM vs. VFQY - Yearly Performance Comparison


2026 (YTD)20252024
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%
VFQY
Vanguard U.S. Quality Factor ETF
7.68%10.24%4.99%

GERM vs. VFQY - Sectors Allocation Comparison


Sectors
GERM
VFQY

Healthcare

99.3%
8.9%

Financial Services

0.4%
18.9%

Basic Materials

-

2.2%

Communication Services

-

2.8%

Consumer Cyclical

-

13.3%

Consumer Defensive

-

9.2%

Energy

-

2.2%

Industrials

-

16.8%

Real Estate

-

-

Technology

-

25.8%

Utilities

-

-

Healthcare

GERM
99.3%
VFQY
8.9%

Financial Services

GERM
0.4%
VFQY
18.9%

Basic Materials

GERM

-

VFQY
2.2%

Communication Services

GERM

-

VFQY
2.8%

Consumer Cyclical

GERM

-

VFQY
13.3%

Consumer Defensive

GERM

-

VFQY
9.2%

Energy

GERM

-

VFQY
2.2%

Industrials

GERM

-

VFQY
16.8%

Real Estate

GERM

-

VFQY

-

Technology

GERM

-

VFQY
25.8%

Utilities

GERM

-

VFQY

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GERM vs. VFQY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GERM

VFQY
VFQY Risk / Return Rank: 4141
Overall Rank
VFQY Sharpe Ratio Rank: 3939
Sharpe Ratio Rank
VFQY Sortino Ratio Rank: 4040
Sortino Ratio Rank
VFQY Omega Ratio Rank: 3636
Omega Ratio Rank
VFQY Calmar Ratio Rank: 4242
Calmar Ratio Rank
VFQY Martin Ratio Rank: 4646
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GERM vs. VFQY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amplify Treatments, Testing and Advancements ETF (GERM) and Vanguard U.S. Quality Factor ETF (VFQY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

GERM vs. VFQY - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


GERMVFQYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.41

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.46

Sharpe Ratio (All Time)

Calculated using the full available price history

0.54

Drawdowns

GERM vs. VFQY - Drawdown Comparison

The maximum GERM drawdown since its inception was 0.00%, smaller than the maximum VFQY drawdown of -37.41%. Use the drawdown chart below to compare losses from any high point for GERM and VFQY.


Loading charts...

Drawdown Indicators


GERMVFQYDifference

Max Drawdown

Largest peak-to-trough decline

0.00%

-37.41%

+37.41%

Max Drawdown (1Y)

Largest decline over 1 year

0.00%

-9.12%

+9.12%

Max Drawdown (3Y)

Largest decline over 3 years

-20.67%

Max Drawdown (5Y)

Largest decline over 5 years

-25.93%

Current Drawdown

Current decline from peak

0.00%

-0.31%

+0.31%

Average Drawdown

Average peak-to-trough decline

0.00%

-6.69%

+6.69%

Ulcer Index

Depth and duration of drawdowns from previous peaks

0.00%

2.46%

-2.46%

Volatility

GERM vs. VFQY - Volatility Comparison

The current volatility for Amplify Treatments, Testing and Advancements ETF (GERM) is 0.00%, while Vanguard U.S. Quality Factor ETF (VFQY) has a volatility of 2.70%. This indicates that GERM experiences smaller price fluctuations and is considered to be less risky than VFQY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GERMVFQYDifference

Volatility (1M)

Calculated over the trailing 1-month period

0.00%

2.70%

-2.70%

Volatility (6M)

Calculated over the trailing 6-month period

0.00%

9.48%

-9.48%

Volatility (1Y)

Calculated over the trailing 1-year period

0.00%

13.52%

-13.52%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

0.00%

18.33%

-18.33%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

0.00%

20.87%

-20.87%

GERM vs. VFQY - Expense Ratio Comparison

GERM has a 0.68% expense ratio, which is higher than VFQY's 0.13% expense ratio.


Dividends

GERM vs. VFQY - Dividend Comparison

GERM has not paid dividends to shareholders, while VFQY's dividend yield for the trailing twelve months is around 1.10%.


PositionTTM20252024202320222021202020192018
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VFQY
Vanguard U.S. Quality Factor ETF
1.10%1.17%1.34%1.38%1.43%0.98%1.22%1.34%1.31%

Frequently Asked Questions


VFQY has higher volatility (2.70%) compared to GERM (0.00%). In terms of maximum drawdown, GERM dropped 0.00% vs VFQY's -37.41%.

On 1-year performance, VFQY leads with 18.92% vs 0.00% for GERM. On fees, VFQY is cheaper at 0.13% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, VFQY has performed better with a 18.92% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

VFQY is cheaper with a 0.13% expense ratio, compared with 0.68% for GERM.

VFQY has the higher dividend yield at 1.10%, compared with 0.00% for GERM.

GERM is categorized as Health & Biotech Equities, while VFQY is Mid Cap Blend Equities. They also come from different issuers: Amplify and Vanguard. Their fees differ too: 0.68% for GERM and 0.13% for VFQY.

Portfolio Optimizer

Find the right allocation for GERM and VFQY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer